Insufficient scRNA-seq data for expression of NANOS2 at single-cell level.
Insufficient scRNA-seq data for expression of NANOS2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 83% | 7.84 | 2204 / 2642 | 2% | 0.03 | 13 / 705 |
lung | 43% | 2.45 | 248 / 578 | 0% | 0.01 | 4 / 1155 |
muscle | 40% | 1.87 | 323 / 803 | 0% | 0 | 0 / 0 |
prostate | 19% | 0.62 | 47 / 245 | 1% | 0.01 | 3 / 502 |
adipose | 19% | 0.62 | 225 / 1204 | 0% | 0 | 0 / 0 |
thymus | 18% | 0.53 | 120 / 653 | 0% | 0 | 0 / 605 |
kidney | 17% | 0.55 | 15 / 89 | 1% | 0.03 | 10 / 901 |
heart | 17% | 0.49 | 146 / 861 | 0% | 0 | 0 / 0 |
adrenal gland | 16% | 0.52 | 42 / 258 | 0% | 0 | 0 / 230 |
liver | 16% | 0.40 | 36 / 226 | 0% | 0 | 0 / 406 |
uterus | 15% | 0.44 | 26 / 170 | 0% | 0 | 0 / 459 |
breast | 15% | 0.44 | 67 / 459 | 0% | 0.00 | 1 / 1118 |
blood vessel | 14% | 0.41 | 189 / 1335 | 0% | 0 | 0 / 0 |
stomach | 12% | 0.33 | 44 / 359 | 1% | 0.10 | 4 / 286 |
esophagus | 13% | 0.35 | 186 / 1445 | 1% | 0.03 | 1 / 183 |
intestine | 13% | 0.36 | 127 / 966 | 0% | 0.01 | 1 / 527 |
skin | 12% | 0.33 | 211 / 1809 | 0% | 0 | 0 / 472 |
spleen | 11% | 0.30 | 27 / 241 | 0% | 0 | 0 / 0 |
pancreas | 10% | 0.26 | 33 / 328 | 0% | 0 | 0 / 178 |
ovary | 9% | 0.27 | 17 / 180 | 0% | 0.00 | 1 / 430 |
peripheral blood | 9% | 0.25 | 86 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 4% | 0.08 | 2 / 45 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.17 | 1 / 29 |
bladder | 0% | 0 | 0 / 21 | 0% | 0.00 | 1 / 504 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0045835 | Biological process | negative regulation of meiotic nuclear division |
GO_0061157 | Biological process | mRNA destabilization |
GO_0007283 | Biological process | spermatogenesis |
GO_0006402 | Biological process | mRNA catabolic process |
GO_0048477 | Biological process | oogenesis |
GO_0030718 | Biological process | germ-line stem cell population maintenance |
GO_0017148 | Biological process | negative regulation of translation |
GO_0000932 | Cellular component | P-body |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0008047 | Molecular function | enzyme activator activity |
GO_0005515 | Molecular function | protein binding |
GO_0003729 | Molecular function | mRNA binding |
GO_0008270 | Molecular function | zinc ion binding |
Gene name | NANOS2 |
Protein name | Nanos homolog 2 (NOS-2) |
Synonyms | NOS2 |
Description | FUNCTION: Plays a key role in the sexual differentiation of germ cells by promoting the male fate but suppressing the female fate. Represses the female fate pathways by suppressing meiosis, which in turn results in the promotion of the male fate. Maintains the suppression of meiosis by preventing STRA8 expression, which is required for premeiotic DNA replication, after CYP26B1 is decreased. Regulates the localization of the CCR4-NOT deadenylation complex to P-bodies and plays a role in recruiting the complex to trigger the degradation of mRNAs involved in meiosis. Required for the maintenance of the spermatogonial stem cell population. Not essential for the assembly of P-bodies but is required for the maintenance of their normal state (By similarity). . |
Accessions | P60321 ENST00000341294.4 |